urotensin II-related peptide (Human) [8595]
urotensin II-related peptide (Human)
| SMILES | CC(C)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)O |
| InChIKey | BKBNRUZZGBUWOM-KOOAXUMWSA-N |
| Sequence | ACFWKYCV |
| HELM | PEPTIDE1{A.C.[Cha].W.K.Y.C.V}$PEPTIDE1,PEPTIDE1,7:R3-2:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | 13 |
| Hydrogen bond donors | 12 |
| Rotatable bonds | 16 |
| Log P | 1.634 |
| Molecular weight (Da) | 1022.5 |
| Stereochemistry info | unspecified |
Database connections
| Model (AF2) | UT |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
urotensin II-related peptide (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Endogenous |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
| Model (AF2) | UT |